Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwMyeloma 2015 | Early treatment and novel therapeutic targets for multiple myeloma

Antonio Palumbo, Jesús San Miguel and Keith Stewart • 11 Apr 2015
iwMyeloma 2015
Multiple Myeloma

At the Myeloma 2015 meeting, Dr Keith Stewart (Mayo Clinic, Scottsdale, AZ) chairs a discussion with Prof Jesús San Miguel (University of Salamanca, Salamanca, Spain) and Prof Antonio Palumbo (University of Torino, Torino, Italy) on new studies of the role of early intervention for smoldering multiple myeloma (MM), treatment strategies for high-risk MM, and promising novel agents for MM.

More from Antonio Palumbo

1:36
Perspectives on future paths to cure multiple myeloma
Antonio Palumbo • 22 Apr 2016
1:27
Frontline therapy for multiple myeloma
Antonio Palumbo • 30 Apr 2016
1:38
Definitions of smouldering myeloma and when to treat
Antonio Palumbo • 29 Apr 2016
1:15
How to diagnose smouldering myeloma
Antonio Palumbo • 23 Apr 2016

More from Jesús San Miguel

Key myeloma highlights from EHA 2023
Enrique Ocio et al. • 9 Jun 2023
1:11
The future of myeloma therapy and where the treatment landscape is moving
Jesús San Miguel • 13 May 2022
1:21
The value of sustained MRD negativity in MM
Jesús San Miguel • 13 May 2022
1:21
MRD evaluation: how, when and for which goal?
Jesús San Miguel • 13 May 2022

More from Keith Stewart

The future of myeloma therapy
Brian Walker et al. • 15 Apr 2023
10:38
Day 2 wrap-up: pushing myeloma boundaries
Gareth Morgan et al. • 27 Mar 2022
11:10
Day 1 highlights: peripheral blood MRD, AB amyloid treatment, single-cell & metabolomics
Faith Davies et al. • 26 Mar 2022
3:09
Immunotherapy in myeloma - where are we?
Keith Stewart • 30 Apr 2020

Related Videos

4:59
MRD as an endpoint for accelerating drug approval in multiple myeloma: updates from the ODAC meeting
Ola Landgren • 13 Apr 2024
1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals